China · Delayed Price · Currency is CNY Shanghai Fosun Pharmaceutical (Group) Company Description
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. manufactures, distributes, and sells pharmaceutical products in Mainland China and internationally.
The company offers pharmaceutical products for oncology and immunomodulation, metabolism and digestive system, anti-infection, central nervous system, and cardiovascular system; and APIs and intermediates, including amino acid, tranexamic acid, levamisole hydrochloride, and clindamycin hydrochloride.
It also provides mRNA vaccines for Covid-19; medical devices for medical cosmetologym personal care, dentistry, injection filling, respiratory health, mobile pre-hospital care, professional in-hospital surgery, and surgical robots and medical consumables for pre-hospital emergency, neurosurgery, orthopedics, and oncology fields; and solutions for biochemical, immune, molecular, microbiological, and pathological diagnosis, as well as chronic care management.
In addition, the company offers online and offline medical services, such as pharmaceuticals and medical devices, consumer healthcare and healthcare commodities, and other comprehensive commodities; specialized medical treatment; and insurance services.
The company was founded in 1994 and is based in Shanghai, China.
| Country | China |
| Founded | 1994 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 40,557 |
| CEO | Yi Liu |
Contact Details
Address: Building A Shanghai, 200233 China | |
| Phone | 86 21 3398 7000 |
| Website | fosunpharma.com |
Stock Details
| Ticker Symbol | 600196 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000000X38 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Wenjie Zhang | Co-President and Co-Chief Executive Officer of Innovative Medicines Division |
| Wang Xingli M.D., Ph.D. | Co-President, Co-Chairman and Co-Chief Executive Officer of Innovative Drug Div., CEO of Global Research & Development Center |
| Jing Li | Co-President, Chief Executive Officer of Established Medicines Manufacturing and Supply Division |
| Yi Liu | President, Chief Executive Officer and Chairman and CEO of Medical Devices Division |
| Xiaohui Guan | Executive Co-Chairman |
| Yuqing Chen | Executive Chairman |
| Rongli Feng | Executive President and Chief Human Resources Officer |
| Zhanyu Chen | Senior Vice President and Chief Financial Officer |
| Kexin Wang | Executive Director |
| Donghua Wang | Senior Vice President |